教程分析案例mar immunization form

forAdultsBeforeadministeringanyvaccines,givethepatientcopiesofallpertinentVaccineInformationStatements(VISs)andmakesurehe/sheunderstandsalrecordcard.

Patientpracticenameandpracticenameand

page10fTypeofStatement(VIS)(signatureorLotDateonDateGiveIM.3Hepatitis(e.g.,HepA,HepA-HepB)GiveIM.3Hepatitis(e.g.,HepB,HepA-HepB)GiveIM.3Human(HPV2,HPV4,Give(MMR)Give(VAR)GiveMeningococcalACWY(e.g.,MenACWY[MCV4],MPSV4)GiveIM.GiveMPSV4Meningococcal(e.g.,MenB)GiveMenBSeepage2torecordinfluenza,p ococcal,zoster,Hib,andothervaccines(e.g.,travelvaccines).TradeNameandAdacelTradeNameandAdacel(SanofiPasteur);Boostrix(GlaxoSmithKlineHavrix(GSK);VaqtaEngerix-B bivaxHBHepA-HPV4,Gardasil,Gardasil9MMRMenactra(SanofiPasteur);MenveoMenomune(SanofiBexsero(GSK);TrumenbaRecordthegenericabbreviation(e.g.,Tdap)orthetradenameforeachvaccine(seetableatright).RecordthefundingsourceofthevaccinegivenaseitherF(federal),S(state),orP(private).Recordtheroutebywhichthevaccinewasgivenaseitherintramuscular(IM),subcutaneous(Subcut),intradermal(ID),intranasal(NAS),ororal(PO)andalsothesitewhereitwasadministeredaseitherRA(rightarm),LA(leftarm),RT(rightthigh),orLT(leftthigh).RecordthepublicationdateofeachVISaswellasthedatetheVISisgiventothepatient.Tomeetthespaceconstraintsofthisformandfederalrequirementsforation,ahealthcaresettingmaywanttokeepareferencelistofvaccinatorsthatudestheirinitialsandtitles.Forcombinationvaccines,fillinarowforeachantigenintheTechnicalcontentreviewedbytheCentersforDiseaseControlandImmunizationAction SaintPaul,Minnesota tg.d/p2023.pdf?Item#P2023forAdults( alrecord

Patientpracticenameandpracticenameand

page20fTypeofStatement(VIS)(signatureorRIV3,LAIV4)GiveV3,V4,ccV3,andRIV3IM.3Pococcal(e.g.,PCV13)GivePCV13 GivePPSV23IMorHibGiveTradeNameandvaccine,trivalent);V4(inactivatedinfluenzavaccine,quadrivalent);inactivatedTradeNameandvaccine,trivalent);V4(inactivatedinfluenzavaccine,quadrivalent);inactivatedinfluenzavaccine,trivalent);RIV3 influenzavaccine,Fluarix(GSK);Flublok(ProteinSciencesCorp.);(GSK);Fluzone,FluzoneIntradermal,FluzoneHigh-Dose(SanofiPasteur)LAIV(liveattenuatedFluMistPrevnar13 ovax23HZVZostavaxHowtoCompletethisRecordthegenericabbreviation(e.g.,Tdap)orthetradenameforeachvaccine(seetableatright).S(state),orP(private).LA(leftarm),RT(rightthigh),orLT(leftthigh).giventothepatient.vaccinatorsthat ludestheirinitialsandtitles.ImmunizationActionCoalition?SaintPaul,Minnesota tg.d/p2023.pdf?Item#P2023–page2第10f(VIS)，并確保他/她了解疫苗的風(fēng)險和益處。務(wù)必提供或更新破傷風(fēng)、白喉、百日咳（Tdap、Td）IM.3A6型肝炎（例如HepA、HepA-HepB）給予IM.3B6（HepB、HepA-HepB）IM.3人乳頭瘤病毒（HPV2、HPV4、HPV9）給予IM.3麻疹、腮腺炎、風(fēng)疹(MMR)GiveSubcut.3(VAR)ACWY（MenACWYMCV4]、MPSV4）MenACWYIM.7MPSV4B（MenB）MenB例如F（聯(lián)邦）、S（州）P（私人）記錄疫苗的肌肉注射(IM)、皮下(Subcut)、(ID)、鼻內(nèi)(NAS)或口服(PO)給藥途徑，以及RA注射的部位（右臂）)、LA（左臂）、RT（右大腿）或LT（左大腿）。VISVIS縮寫商品名稱和制造商TdapAdacel（賽諾菲）；Boostrix（[GSK]）TdDecavac、Tenivac（賽諾菲）；通用Td（MA生物實驗室）HepAHavrix()；Vaqta（HepBEngerix-BTwinrixbivax)）HPV2)MMRMMR VAR MenACWYMenactra（賽諾菲 MPSV4Menomune（賽諾菲 MenB #P2023第20f（續(xù)） V3、V4、ccV3、RIV3、LAIV4）給 V3、V4、ccV3和RIV3IM.3給LAIV4肺炎球菌結(jié)合物（PCV13）PCV13肺炎球菌多糖（PPSV23）PPSV23IM(HZV)Subcut.3Hib給予IM.31Tdap/Td、甲型肝炎、乙型肝炎、HPV、MMR、水痘、MenACWYMenB例如F（聯(lián)邦）、S（州）P（私人）記錄疫苗的肌肉注射(IM)、皮下(Subcut)、(ID)、鼻內(nèi)(NAS)或口服(PO)給藥途徑，以及RA注射的部位（右臂）)、LA（左臂）、RT（右大腿）或LT（左大腿）。VISVIS V4（滅活流感疫苗，四價）；cc（基于細胞培養(yǎng)的滅活流感疫苗，三價）；RIV3（滅活重組流感疫苗，三價）